QTTB Q3 2020 Earnings — Q32 Bio Inc. Revenue & Financial Results | Market Cap Arena

QTTBQ32 Bio Inc.

$83M

Q3 2020 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$567,000+28.6% YoY

Gross Profit

$00.0% margin

Operating Income

-$28M-4986.4% margin

Net Income

-$28M-4979.2% margin

EPS (Diluted)

$-11.24

QoQ Revenue Growth

+0.0%

Cash Flow

Operating Cash Flow

-$29M

Free Cash Flow

-$29M

Stock-Based Comp.

$0

Balance Sheet

Total Assets

$228M

Total Liabilities

$58M

Stockholders' Equity

$170M

Cash & Equivalents

$178M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$567,000	$441,000	+28.6%
Gross Profit	$0	$0	—
Operating Income	-$28M	-$31M	+9.6%
Net Income	-$28M	-$30M	+4.7%